Fundz

KBI Biopharma, Inc. Names Peter Carbone as Chief Quality Officer

PRIVATEApr 01, 2024

Company

KBI Biopharma

DurhamManufacturingBiotechnologyLife Science

Description

KBI Biopharma, Inc. (KBI) announced the appointment of Peter Carbone as the new Chief Quality Officer to strengthen the company's expertise in quality and regulations. With over 35 years of experience in business operations, quality, and technological leadership in various areas of the life sciences spectrum, Peter will lead KBI’s Quality & Regulatory Affairs team to drive compliance and regulatory initiatives for global clientele.

Quick answer

KBI Biopharma, Inc. Names Peter Carbone as Chief Quality Officer (April 1, 2024). KBI Biopharma is based in Durham, North Carolina, United States.

What did KBI Biopharma announce on April 1, 2024?
KBI Biopharma, Inc. (KBI) announced the appointment of Peter Carbone as the new Chief Quality Officer to strengthen the company's expertise in quality and regulations. With over 35 years of experience in business operations, quality, and technological leadership in various areas of the life sciences spectrum, Peter will lead KBI’s Quality & Regulatory Affairs team to drive compliance and regulatory initiatives for...
What does KBI Biopharma do?
KBI Biopharma is an award-winning biopharmaceutical contract services organization providing fully-integrated, accelerated drug development and biomanufacturing services to pharmaceutical and biotechnology companies...
Where is KBI Biopharma based?
KBI Biopharma is based in Durham, North Carolina, United States.
Which similar companies made leadership changes around the same time?
Bio-Rad Laboratories (March 20, 2024), Lonza (April 2, 2024), Dow (April 2, 2024) and XTPL (April 2, 2024) also announced leadership changes within 45 days of KBI Biopharma.

Source: Fundz verified event record.

Other recent leadership changes in Life Science and Manufacturing

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at KBI Biopharma, and when

A new leader at KBI Biopharma brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day KBI Biopharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at KBI Biopharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at KBI Biopharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

KBI Biopharma

Location

Durham, North Carolina, United States

About

KBI Biopharma is an award-winning biopharmaceutical contract services organization providing fully-integrated, accelerated drug development and biomanufacturing services to pharmaceutical and biotechnology companies globally. With each of our 500+ client partners, we have worked closely to personalize and rapidly accelerate their drug development programs. Built upon a foundation of world-class analytical capabilities, we deliver efficient process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs. KBI is proud to be a JSR Life Sciences Company.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment KBI Biopharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Maggie
Likely contact at this company
••••••••@••••••••

See Maggie's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for KBI Biopharma's next move

Learn about Strategic plan

KBI Biopharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.